Acuvi Q1 2023: Initial take - Redeye - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

Acuvi Q1 2023: Initial take - Redeye

{newsItem.title}

Redeye was hoping for a bit more in terms of growth, and so did Acuvi we believe. Sales in the first quarter were flat Y/Y, but declining when adjusted for currency effects. Preliminary numbers were already published, so no big surprise in today’s Q1 report. On a positive note, we see very solid gross margins and a well contained cost base. Moreover, Acuvi now has a permanent CEO as Olof Stranding will remain at the helm. Despite a slow Q1, we believe sales will recover during the year as a number of large business projects start materializing. We will however have to lower our near-term growth forecasts.

Länk till analysen i sin helhet: https://www.redeye.se/research/903344/acuvi-q1-2023-initial-take?utm_source=finwire&utm_medium=RSS

Nyheter om Acuvi

Läses av andra just nu

Om aktien Acuvi

Senaste nytt